Diet News and Research

Latest Diet News and Research

Mrs. Obama on childhood obesity

Last month First Lady Michelle Obama launched a programme called “Let’s Move” aiming at reducing and eradicating the childhood obesity epidemic in the existing generation so that the nation as a whole attains a healthy adulthood in the coming decades.

18 Mar 2010

ONGLYZA-metformin combination: FDA accepts NDA for review

Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.

17 Mar 2010

Stomach wrap operations more effective than acid suppression tablets in severe acid reflux treatment

Stomach wrap operations may be more effective than acid suppression tablets in the treatment of severe acid reflux, according to a new Cochrane Systematic Review. The study shows a more pronounced improvement in symptoms shortly after surgery than with drug treatment.

17 Mar 2010

Low-impact, weight-bearing exercise does not affect bone density during weight loss

While there are many benefits of losing weight, weight reduction also might negatively affect bones in the body. During weight loss, bones are being remodeled - breaking down old bone and forming new bone - at an accelerated rate.

17 Mar 2010

Pfizer-FRSQ-MSSS Chronic Disease Fund for chronic-disease prevention and management initiatives

The Fonds de la recherche en santé du Québec in partnership with the Ministère de la Santé et des Services sociaux and Pfizer Canada, is announcing the creation of the Pfizer-FRSQ-MSSS Chronic Disease Fund. Established with an investment of $5 million from Pfizer Canada, this research grant program, coordinated by the FRSQ, is open to Quebec-based researchers who work in collaboration with health professionals.

17 Mar 2010

Research shows clove is the best antioxidant spice

Using spices eaten in the Mediterranean diet as natural antioxidants is a good way forward for the food industry, given the beneficial health effects of these products. This has been shown by researchers from the Miguel Hern-ndez University (UMH), who have put the clove in first place.

17 Mar 2010

Lipitor 80 mg may help reduce risk of major cardiovascular events in high-risk patients

Lipitor® (atorvastatin calcium) 80 mg was associated with a significantly reduced risk of major cardiovascular events compared with Lipitor 10 mg among patients with both coronary heart disease (CHD) and chronic kidney disease (CKD) who were obese or had metabolic syndrome. These data, from two sub-analyses of the Treating to New Targets (TNT) trial that were designed and completed following the completion of TNT, were presented today at the 59th Annual Scientific Session of the American College of Cardiology (ACC) in Atlanta, Ga.

16 Mar 2010

This Brain Awareness Week, Canadians are urged to take control and protect their health

With the prevalence of dementia expected to reach 1.1 million Canadians within a generation, taking care of your brain health has never been more important.

16 Mar 2010

Tips for reducing LDL cholesterol

Cardiovascular disease is the No.1 killer in North America. And high cholesterol is one of the primary risk factors of coronary heart disease and stroke. According to the Heart and Stroke Foundation, almost 40% of Canadian adults are classified as having high blood cholesterol levels.

16 Mar 2010

Obesity limits body's ability to fight infections

Obesity may limit the body's ability to develop immunity to influenza viruses, particularly secondary infections, by inhibiting the immune system's ability to "remember" how it fought off previous similar bouts of illness, according to new research from the University of North Carolina at Chapel Hill.

16 Mar 2010

MIF exhibits potential as viable therapeutic target for Type 2 diabetes

An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research.

16 Mar 2010

NKF: Certain ethnic minorities are at higher risk for developing CKD

Certain ethnic minorities, including African Americans and Hispanics, are at a higher risk than the general population for developing potentially life-threatening chronic kidney disease (CKD), which has been linked to higher rates of diabetes and high blood pressure, according to the National Kidney Foundation.

16 Mar 2010

Global Nutrition Transition Conference: Physicians and nutrition scientists to discuss solutions for preventing obesity

Physicians and nutrition scientists from around the world gathered today in Orlando for the opening of the Global Nutrition Transition Conference in order to discuss emerging trends and grass roots solutions to the global obesity epidemic employing balanced nutrition and teaching healthy active lifestyles.

16 Mar 2010

Youngsters create short films to address obesity and eating disorders

Youth homelessness and eating disorders are two areas of health highlighted by young people in Cardiff in a project that uses digital technology to create short films which detail public health issues.

16 Mar 2010

Ranbaxy resolves generic Actos patent litigation

Ranbaxy Laboratories Limited, along with its wholly owned subsidiary Ranbaxy Pharmaceuticals Inc. (collectively, "Ranbaxy"), announced today that they have reached an agreement with Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals North America resolving outstanding patent litigation related to Ranbaxy's generic equivalent version of Actos® (Pioglitazone Hydrochloride) 15 mg, 30 mg and 45 mg tablets.

15 Mar 2010

Healthways, Blue Zones establish Healthways-Blue Zones Vitality Quest to improve community well-being

Today, Healthways, Inc. and Blue Zones, LLC, announced the establishment of Healthways-Blue Zones Vitality QuestSM, an exclusive, strategic relationship to create, support and sustain a national movement to improve community health and well-being, initially for cities in the U.S.

15 Mar 2010

Valsartan delays progression to type 2 diabetes in IGT patients: NAVIGATOR study

Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT), a common pre-diabetic condition.

15 Mar 2010

NDA for BYDUREON: FDA issues complete response letter

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for BYDUREON™ (exenatide for extended-release injectable suspension).

15 Mar 2010

Obese type 2 diabetics carry mitochondrial proteins that reduce response to physical exercise

Diet and aerobic exercise are highly effective for the treatment of type 2 diabetes, but not for obese subjects that have developed the disease when very young. A study at the Institute for Research in Biomedicine and Trinity College in Dublin demonstrates that obese subjects between 18 and 25 years of age carry mitochondrial proteins and genes that work abnormally and that these anomalies contribute to generating insulin resistance and a reduced response to physical exercise.

15 Mar 2010

Childhood obesity: Genetic variation could be a factor

Increasing childhood obesity has worried governments and public health advisers in many countries. But a study of 300 children with severe obesity by the University of Cambridge and the Wellcome Trust Sanger Institute, suggest the problem may be more complicated than simply bad diet, overeating, or lack of exercise.

12 Mar 2010

Diet News and Research

Latest Diet News and Research

Mrs. Obama on childhood obesity

ONGLYZA-metformin combination: FDA accepts NDA for review

Stomach wrap operations more effective than acid suppression tablets in severe acid reflux treatment

Low-impact, weight-bearing exercise does not affect bone density during weight loss

Pfizer-FRSQ-MSSS Chronic Disease Fund for chronic-disease prevention and management initiatives

Research shows clove is the best antioxidant spice

Lipitor 80 mg may help reduce risk of major cardiovascular events in high-risk patients

This Brain Awareness Week, Canadians are urged to take control and protect their health

Tips for reducing LDL cholesterol

Obesity limits body's ability to fight infections

MIF exhibits potential as viable therapeutic target for Type 2 diabetes

NKF: Certain ethnic minorities are at higher risk for developing CKD

Global Nutrition Transition Conference: Physicians and nutrition scientists to discuss solutions for preventing obesity

Youngsters create short films to address obesity and eating disorders

Ranbaxy resolves generic Actos patent litigation

Healthways, Blue Zones establish Healthways-Blue Zones Vitality Quest to improve community well-being

Valsartan delays progression to type 2 diabetes in IGT patients: NAVIGATOR study

NDA for BYDUREON: FDA issues complete response letter

Obese type 2 diabetics carry mitochondrial proteins that reduce response to physical exercise

Childhood obesity: Genetic variation could be a factor

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Diet News and Research

Latest Diet News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in